Corneal toxicity reported with mirvetuximab soravtansine

Published Date: 30 Oct 2024

For patients receiving mirvetuximab soravtansine (MIRV) treatment for primary gynecologic malignancies, corneal toxicity is not uncommon, but usually resolves, according to a study presented at the annual meeting of the American ...

Read Full News

Latest News

Mindfulness App Eases Mental Burden in Eye Disease

A digital mindfulness-based intervention significantly reduces symptoms of anxiety and depression and perceived stress in adults with noninfectious uveitis, a clinical trial shows.
HTTP error: 503

A Faster Path to an Artificial Eye

3D printing can greatly improve access to the prosthetics.

Gene-Agnostic Therapy Sees 3-Year Gain in Severe Vision Loss

A treatment that targets dysfunctional photoreceptors regardless of the underlying genetic mutation leads to improved functional vision in advanced severe vision loss.
HTTP error: 503HTTP error: 503

Todays Updates

Enhancing Comprehensive Biomarker Testing and Biomarker-Directed Treatment Selection

Enhancing Comprehensive Biomarker Testing and Biomarker-Directed Treatment Selection

Advancing Care in ES-SCLC: Personalized Strategies, New Therapies, and Real-World Insights

Advancing Care in ES-SCLC: Personalized Strategies, New Therapies, and Real-World Insights

Adjuvant Combination for Kidney Cancer Gets FDA's Blessing

Belzutifan and pembrolizumab together reduced the risk of disease recurrence or death

FDA Approves Prostate Cancer Combo That Warranted Advisory Meeting

Capivasertib plus abiraterone combination lands indication for PTEN-deficient tumors

Talquetamab Regimens Boost Survival in Multiple Myeloma

"Combinations represent additional options for early-line treatment," researcher says

In High-Risk B-Cell ALL, Swapping Out Chemo for Blinatumomab Improves Outcomes

The bispecific T-cell engager also reduced toxicity in newly diagnosed kids

Timely 'Nudges' Can Help Encourage More End-of-Life Conversations in Cancer

A combination of clinician and patient prompts worked best, but talks remained infrequent

Todays Updates

Enhancing Comprehensive Biomarker Testing and Biomarker-Directed Treatment Selection

Enhancing Comprehensive Biomarker Testing and Biomarker-Directed Treatment Selection

Advancing Care in ES-SCLC: Personalized Strategies, New Therapies, and Real-World Insights

Advancing Care in ES-SCLC: Personalized Strategies, New Therapies, and Real-World Insights

Adjuvant Combination for Kidney Cancer Gets FDA's Blessing

Belzutifan and pembrolizumab together reduced the risk of disease recurrence or death

FDA Approves Prostate Cancer Combo That Warranted Advisory Meeting

Capivasertib plus abiraterone combination lands indication for PTEN-deficient tumors

Talquetamab Regimens Boost Survival in Multiple Myeloma

"Combinations represent additional options for early-line treatment," researcher says

In High-Risk B-Cell ALL, Swapping Out Chemo for Blinatumomab Improves Outcomes

The bispecific T-cell engager also reduced toxicity in newly diagnosed kids

Timely 'Nudges' Can Help Encourage More End-of-Life Conversations in Cancer

A combination of clinician and patient prompts worked best, but talks remained infrequent

Latest News

A digital mindfulness-based intervention significantly reduces symptoms of anxiety and depression and perceived stress in adults with noninfectious uveitis, a clinical trial shows.

Patients who lived more than 30 miles away from their specialists had median annual expenses over $400 in Tennessee and over $300 in California.

3D printing can greatly improve access to the prosthetics.
HTTP error: 503HTTP error: 503HTTP error: 503

News All Time

Trump Showing His Age? Nasal Spray Recalled; Elton John on Losing Sight

Health news and commentary gathered by MedPage Today staff
HTTP error: 503HTTP error: 503

Higher-Dose Aflibercept Similar to Standard Dose in Severe AMD Variant

Patients with PCV gain standard-dose benefits, with less-frequent dosing

Color Blindness and Bladder Cancer: A Bad Combination for Survival?

Study suggests inability to identify blood in urine may delay diagnosis and reduce survival

Contaminated Water Blamed for 10 Deaths; FDA Rejections; Mammograms for Heart Risks?

Health news and commentary gathered by MedPage Today staff
HTTP error: 503HTTP error: 503HTTP error: 503HTTP error: 503HTTP error: 503HTTP error: 503HTTP error: 503

Some Blind Fans to Experience Super Bowl With Tactile Device That Tracks Ball

About 10 blind and low-vision fans will have an opportunity to use the technology
HTTP error: 503

Dry Eye: Handmaiden to Many Autoimmune Conditions, Not Just Sjogren's Disease

Taiwanese study puts numbers to common but poorly studied phenomenon

Recommended News For You

Recommended Articles For You

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot